Department of Orthodontics, School of Dentistry, Mashhad University of Medical Sciences.
Department of Pediatric Surgery, Arya Hospital, Islamic Azad University of Mashhad, Mashhad, Iran.
J Craniofac Surg. 2022;33(2):e194-e200. doi: 10.1097/SCS.0000000000008254.
Alveolar bone grafts are the golden standard in treating patients with oral cleft and hence, the long-term success of this treatment is the subject of many studies. The aim of this study was to systematically review literature that examined the long-term stability of alveolar bone grafting in patients with cleft lip and palate.
In this study, data was collected via a comprehensive search of random and nonrandom studies evaluating the success of bone grafts in patients with cleft lip and palate in ISI Web of Science, EMBASE, Scopus, Medline, and Cochrane Central Register of Controlled Trials from the beginning until July 3, 2020. Also, a search was conducted for ongoing studies in the trial registry and a hand search of related gray literature and references of the relevant studies. The relevant data of the included studies were extracted using predefined extraction forms. Meta-analysis was performed using inverse-variance for calculating the pooled outcome of outcome measures. The pooled mean success rate of alveolar bone graft and mean difference of cleft volume after 1 year was presented as the outcome of the analysis.
Eight studies (1 randomized clinical trial study and 7 controlled prospective studies) were included in this meta-analysis. The results of the analyses showed that the total percentage of secondary alveolar success in the follow-up period of at least 1 year according to the Bergland index was 76.52% (pooled success = 76.52%, 44.92-98.10). Also, bone defect in the cleft area reduced significantly after bone grafting (MD = 0.62 cm3, 0.48-0.75, P < 0.00001). The total percentage of bone filling after 1 year and according to CBCT (cone beam computed tomography) was about 63.38%, and the rate of definite natural eruption of canine within the graft was 80.89%.
The total success rate of secondary alveolar bone grafting in the follow-up period of at least 1 year was clinically significant and alveolar bone grafting significantly reduced bone defect volume. Also, there was no difference in the amount of bone remaining after 1 year in patients whose canine had erupted through the grafted bone and in those whose canine had not erupted.
牙槽骨移植是治疗口腔裂隙患者的金标准,因此,这种治疗的长期效果是许多研究的主题。本研究的目的是系统地回顾文献,检查唇腭裂患者牙槽骨移植的长期稳定性。
本研究通过综合检索 ISI Web of Science、EMBASE、Scopus、Medline 和 Cochrane 对照试验中心注册库中评估唇腭裂患者骨移植成功率的随机和非随机研究,收集数据,检索时间从 2020 年 7 月 3 日开始。此外,还对试验登记处正在进行的研究进行了检索,并对手头的相关灰色文献和相关研究的参考文献进行了检索。使用预定义的提取表格提取纳入研究的相关数据。使用逆方差法进行荟萃分析,计算结局指标的汇总结局。以分析的结果呈现牙槽骨移植总成功率和 1 年后裂隙体积的平均差异。
本荟萃分析纳入了 8 项研究(1 项随机临床试验研究和 7 项对照前瞻性研究)。分析结果表明,根据 Bergland 指数,在至少 1 年的随访期内,二次牙槽成功的总百分比为 76.52%(汇总成功率=76.52%,44.92-98.10)。此外,骨移植后裂隙区的骨缺损明显减少(MD=0.62cm3,0.48-0.75,P<0.00001)。1 年后根据 CBCT(锥形束 CT)进行的骨填充总百分比约为 63.38%,植入骨内犬牙的明确自然萌出率为 80.89%。
至少 1 年随访期内,二次牙槽骨移植的总成功率具有临床意义,牙槽骨移植显著减少了骨缺损体积。此外,在植入骨内犬牙萌出和未萌出的患者中,1 年后残留骨量无差异。